PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1239995
PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1239995
Global exosome research products market is projected to register a substantial CAGR of 35.6% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030. Market Segmentation: Global Exosome Research Products Market By Product (Instruments, and Consumables), Indication (Cancer and Non-Cancer), Application (Therapeutics and Diagnosis), End Users (Hospitals, Clinical Testing Laboratories, Research Centers, Pharmaceutical and Biotechnology Company, Academic Institutes, and Others), Distribution Channel (Third Party Distributors, Online, Direct Tender, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Arica) Industry Trends and Forecast to 2030
Hologic Inc.
Luminex Corporation
Thermo Fisher Scientific
Agilent Technologies, Inc.
RoosterBio, Inc.
Microgentas
Cell Guidance Systems LLC
QIAGEN
FUJIFILM Irvine Scientific( a subsidiary of FUJIFILM Holdings Corporation)
CUSABIO TECHNOLOGY LLC
NEXOSOME-ONCOLOGY
Norgen Biotek Corp.
Miltenyi Biotec
Aethlon Medical, Inc.,
System Biosciences, LLC.
AMSBIO
ExoDx (Acquired By Bio-Techne)
BioVision Inc. (Acquired By Abcam plc)
HBMLS (Acquired by Lonza)
Creative Bioarray
NanoSomiX
Novus Biologicals
Beckman Coulter, Inc.
JSR Micro NV
Hitachi, Ltd.
INOVIQ
ProteoGenex
Audubon Bioscience